A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk
Breast Cancer Research and TreatmentPublished 27 February 2007Open access
Claire E. Wakefield, Bettina Meiser, Judi Homewood, Michelle Peate, Alan Taylor, Elizabeth Lobb
Citations79
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Decision aids are an effective decision-support strategy for women considering genetic testing for breast/ovarian cancer risk, and are most effective before the patient has made a decision, which is generally at the point of having blood drawn.
Abstract
Decision aids are an effective decision-support strategy for women considering genetic testing for breast/ovarian cancer risk, and are most effective before the patient has made a decision, which is generally at the point of having blood drawn.
Keywords
MedicineHealth ProfessionsBiochemistry, Genetics and Molecular Biology
Acta Psychiatrica ScandinavicaThe Hospital Anxiety and Depression Scale
46,617 Citations1983A. S. Zigmond, R. P. Snaith
It is suggested that the introduction of the scales into general hospital practice would facilitate the large task of detection and management of emotional disorder in patients under investigation and treatment in medical and surgical departments.
Psychosomatic MedicineImpact of Event Scale: A Measure of Subjective Stress
7,877 Citations1979Mardi J. Horowitz, Nancy Wilner +1 more
A scale of current subjective distress, related to a specific event, was based on a list of items composed of commonly reported experiences of intrusion and avoidance, and responses indicated that the scale had a useful degree of significance and homogeneity.
Cochrane Database of Systematic ReviewsDecision aids for people facing health treatment or screening decisions
6,616 Citations2017Dawn Stacey, France Légaré +9 more
Decision aids reduced the proportion of undecided participants and appeared to have a positive effect on patient-clinician communication, and those exposed to a decision aid were either equally or more satisfied with their decision, the decision-making process, and the preparation for decision making compared to usual care.
The American Journal of Human GeneticsGenetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
3,047 Citations1998Deborah Ford, Douglas F. Easton +36 more
The lifetime risk of breast cancer appears similar to the risk in BRCA1 carriers, but there was some suggestion of a lower risk in bRCA2 carriers <50 years of age.
BiometricsA Note on Robust Variance Estimation for Cluster‐Correlated Data
2,523 Citations2000Rick L. Williams
This brief note presents a general proof that the estimator is unbiased for cluster-correlated data regardless of the setting.
Medical Decision MakingValidation of a Decisional Conflict Scale
2,454 Citations1995Annette M. O’Connor
The psychometric properties of a decisional conflict scale (DCS) that elicits health-care consumers' uncertainty in making a health-related decision and the factors contributing to the uncertainty are acceptable.
BMJDeveloping a quality criteria framework for patient decision aids: online international Delphi consensus process
1,781 Citations2006Glyn Elwyn
Criteria were given the highest ratings where evidence existed, and these were retained, and developers, users, and purchasers of patient decision aids now have a checklist for appraising quality.
Medical Decision MakingValidation of a Decision Regret Scale
1,441 Citations2003Jamie C. Brehaut, Annette M. O’Connor +5 more
The A5- item scale is a useful indicator of health care decision regret at a given point in time and was greater among those who changed their decisions than those who did not.
New England Journal of MedicineEfficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer
1,413 Citations1999Lynn C. Hartmann, Daniel J. Schaid +12 more
In women with a high risk of breast cancer on the basis of family history, prophylactic mastectomy can significantly reduce the incidence of Breast cancer.
New England Journal of MedicineBreast Cancer after Prophylactic Bilateral Mastectomy in Women with a<i>BRCA1</i>or<i>BRCA2</i>Mutation
963 Citations2001Hanne Meijers-Heijboer, Bert van Geel +10 more
In women with a BRCa1 or BRCA2 mutation, prophylactic bilateral total mastectomy reduces the incidence of breast cancer at three years of follow-up.
BMJDecision aids for patients facing health treatment or screening decisions: systematic review
877 Citations1999Annette M. O’Connor, Alaa Rostom +7 more
The LancetFirst results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial
742 Citations2002J Cuzick, JF Forbes +7 more
European Journal of CancerScreening for anxiety and depression in cancer patients: the effects of disease and treatment
416 Citations1994T. Ibbotson, Peter Maguire +3 more
The General Health Questionnaire 28, Hospital Anxiety and Depression Scale (HADS), and Rotterdam Symptom Checklist seemed promising in their ability to detect anxiety and depression in cancer patients, but all three questionnaires have a definite role in screening out anxiety and depressed patients.
Journal of Clinical OncologyOutcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers
405 Citations2002Lauren Scheuer
This study provides prospective evidence that genetic counseling and testing increased surveillance and led to risk-reducing operations, which resulted in diagnosis of early-stage tumors in patients with BRCA1 and BRCa2 mutations.
Journal of Psychosomatic ResearchConstruct validation of the hospital anxiety and depression scale with clinical populations
378 Citations2000Marie Johnston, Beth Pollard +1 more
There was support for the validity of the HADS for all three questions, however, there were some evidences of individual items performing poorly, and there was little evidence that removing items would improve it.
British Journal of CancerCancer risks among BRCA1 and BRCA2 mutation carriers
331 Citations2007Ephrat Levy‐Lahad, Eitan Friedman
BRCA1 and BRCA2 mutations increase breast and ovarian cancer risks substantially enough to warrant risk reduction surgery, despite variable risk estimates.
The LancetPresymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation
306 Citations2000E.J. Meijers-Heijboer, L.C. Verhoog +9 more
In a clinical setting, a high demand for BRCa1 and BRCA2 testing by unaffected women at risk, and of prophylactic surgery by unaffectedWomen with the mutation is shown.
Psycho-OncologyPsychological impact of genetic testing for cancer susceptibility: an update of the literature
300 Citations2005Bettina Meiser
An overview of the rapidly evolving body of literature on the psychological impact of genetic testing for hereditary breast/ovarian cancer susceptibility, hereditary non‐polyposis colorectal cancer (HNPCC) and familial adenomatous polyposis (FAP) is presented.
Medical Decision MakingRandomized Trial of a Portable, Self-administered Decision Aid for Postmenopausal Women Considering Long-term Preventive Hormone Therapy
252 Citations1998Annette M. O’Connor, Peter Tugwell +8 more
It is concluded that tailored decision aids prepare women for decision making better than do general pamphlets.
Patient Education and CounselingThe multi-dimensional measure of informed choice: a validation study
243 Citations2002Susan Michie, Elizabeth Dormandy +1 more
The MMIC has been shown to be psychometrically robust in pregnant women offered the choice to undergo prenatal screening for Down syndrome and receiving a low-risk result, and the lack of association between the MMIC and anxiety shows construct (discriminant) validity.
Journal of Clinical OncologyOutcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in <i>BRCA</i> Mutation Carriers
243 Citations2002Lauren Scheuer, Noah D. Kauff +10 more
JNCI MonographsDecision Aids for Patients Considering Options Affecting Cancer Outcomes: Evidence of Efficacy and Policy Implications
240 Citations1999Annette M. O’Connor, Valerie Fiset +6 more
The purpose of this paper is to review published evidence about the efficacy of decision aids focused on cancer outcomes, several recommendations for research are made, and dissemination issues are identified.
American Journal of Medical Genetics Part AGenetic testing for a <i>BRCA1</i> mutation: Prophylactic surgery and screening behavior in women 2 years post testing
198 Citations2003Jeffrey R. Botkin, Ken R. Smith +11 more
The authors' results indicate utilization of genetic testing by a majority of high‐risk individuals who received information about testing, and both carriers and non‐carriers increased their utilization of mammography and breast self‐exam following testing.
European Journal of CancerAre we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer?
179 Citations1999Angela Hall, Roger A’Hern +1 more
Questions are raised about the use of both the HADS and the RSCL as suitable research or screening instruments for detection of psychological morbidity in early breast cancer.
Breast Cancer Research and TreatmentOne Year Follow-Up of Women Opting for Presymptomatic Testing for BRCA1 and BRCA2: Emotional Impact of the Test Outcome and Decisions on Risk Management (Surveillance or Prophylactic Surgery)
173 Citations2002Litanja Lodder, Petra G. Frets +11 more
Most women who underwent prophylactic mastectomy were satisfied with this decision, despite a perceived negative impact on body image, the intimate relationship and physical wellbeing.
Psycho-OncologyPsychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer
166 Citations2001Belinda Thewes, Bettina Meiser +1 more
Analysis of correlation coefficients between the IES, breast cancer‐related events and attitudes and other standardized measures of distress and general somatic concern, provide some preliminary support for the concurrent and discriminative validity of the Ies amongst women at increased risk of developing hereditary breast cancer.
British Journal of CancerThe impact of genetic counselling about breast cancer risk on women’s risk perceptions and levels of distress
162 Citations1999A. Cull, Elaine Anderson +4 more
The counselling offered was effective in increasing the accuracy of risk perceptions without causing distress to those who initially underestimated their risk, and it is worrying that inaccuracies persisted.
Cancer Epidemiology Biomarkers & PreventionUptake Rates for Breast Cancer Genetic Testing: A Systematic Review
157 Citations2006Mary E. Ropka, Jennifer Wenzel +3 more
In addition to clinical characteristics, research methodologic issues are likely to be major determinants of variability in published breast cancer genetic testing uptake rates, and an understanding of these issues will clarify to clinicians why their clinical experience may not be congruent with published rates and help guide future research.
Patient Education and CounselingIs anxiety a suitable measure of decision aid effectiveness: a systematic review?
140 Citations2003Hilary Bekker, France Légaré +3 more
As raised levels of anxiety are associated with both more effective decision strategies and stressful health interventions, anxiety is an inappropriate measure to employ when evaluating decision aids.
European Journal of CancerPsychological impact of genetic testing in women from high-risk breast cancer families
128 Citations2002Bettina Meiser, Phyllis Butow +6 more
Data show that non-carriers derive psychological benefits from genetic testing, and women testing positive may anticipate a sustained increase in breast cancer distress following disclosure, although no other adverse psychological outcomes were observed in this group.
Preventive MedicineTailored Risk Notification for Women with a Family History of Breast Cancer
97 Citations1999Roshan Bastani, Annette E. Maxwell +3 more
The intervention was successful in increasing mammography rates among high-risk women 50+ years of age, and further work is needed to determine why it was ineffective among younger women.
JNCI MonographsIs There a Use for Tailored Print Communications in Cancer Risk Communication?
94 Citations1999Barbara K. Rimer, Barry Glassman
The use of TPCs in the communication of cancer risk shows great promise, however, particularly as knowledge evolves regarding both the nature of risk and the most effective tailoring of health communication messages.
Journal of Clinical OncologyClinical Characteristics Affect the Impact of an Uninformative DNA Test Result: The Course of Worry and Distress Experienced by Women Who Apply for Genetic Testing for Breast Cancer
93 Citations2006Sandra van Dijk, Daniëlle R. M. Timmermans +4 more
Women with an uninformative result form a heterogeneous group of test applicants, and the subpopulation of those with both a personal history of cancer and a relatively high pedigree-based risk expressed the highest levels of worry 7 months after DNA testing.
The Medical Journal of AustraliaThe National Breast Cancer Centre
90 Citations1995Sally Redman, John H. Kearsley
This newly established body will work to focus the national effort to control breast cancer.
Cancer Epidemiology Biomarkers & PreventionUtilization of BRCA1/BRCA2 Mutation Testing in Newly Diagnosed Breast Cancer Patients
89 Citations2005Marc D. Schwartz, Caryn Lerman +7 more
Genetics in MedicineWhat’s the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer
57 Citations2005Sandra van Dijk, Wilma Otten +6 more
No support was found for the suggestion that the nature of uninformative test results is often misunderstood, and an uninformatives test result did not affect the positive mammography intentions of both affected and unaffected women.
Journal of Genetic CounselingDevelopment and Pilot Testing of Two Decision Aids for Individuals Considering Genetic Testing for Cancer Risk
55 Citations2007Claire E. Wakefield, Bettina Meiser +7 more
Two decision aids for individuals considering genetic testing for hereditary breast/ovarian cancer and hereditary non-polyposis colorectal cancer susceptibility were developed and pilot tested with 43 individuals who had previously considered geneticTesting for these cancer syndromes.
European Journal of CancerImpact of an information booklet on satisfaction and decision-making about BRCA genetic testing
51 Citations2006Julien Mancini, Catherine Noguès +15 more
In addition to a consultation providing more tailored information, a standardized written document improved the decision-making process involved in giving informed consent to genetic testing.
American Journal of Medical Genetics Part C Seminars in Medical GeneticsReferral to cancer genetic counseling: Are there stages of readiness?
48 Citations2006Suzanne M. O’Neill, June A. Peters +3 more
Outcome of genetics referral in 43 affected women attending a breast cancer treatment program who were referred based on having BRCA mutation carrier risks ≥10% was investigated.
Annals of Behavioral MedicineAssociations between relationship support and psychological reactions of participants and partners to BRCA1 and BRCA2 testing in a clinic-based sample
48 Citations2004Sharon L. Manne, Janet Audrain +4 more
The results of this study suggest that the majority of couples respond supportively during the test experience, but for a small subset of couples the process can strain the relationship.
JNCI Journal of the National Cancer InstituteStandard Consultations Are Not Enough to Ensure Decision Quality Regarding Preference-Sensitive Options
48 Citations2003Annette M. O’Connor, Albert G. Mulley +1 more
The first randomized controlled trial of a decision board for women considering chemotherapy for lymph node-negative breast cancer is reported, confirming the efficacy of their particular approach in achieving improvement in decision quality and adding to the mounting evidence of the effectiveness of decision aids.
Medical Decision MakingA Randomized Controlled Trial of a Decision Aid for Women at Increased Risk of Ovarian Cancer
37 Citations2006Kerry Tiller, Bettina Meiser +6 more
The decision aid is an effective and acceptable strategy for patient education to facilitate an inclusive and informed decision-making process about managing ovarian cancer risk.
Psycho-OncologyEvaluation of the needs and concerns of partners of women at high risk of developing breast/ovarian cancer
30 Citations2005Shab Mireskandari, Bettina Meiser +4 more
Investigation of the experience of partners of women at high risk of developing breast/ovarian cancer finds partners of carriers and women with unknown mutation status were found to be more distressed than partners of non‐carriers, with partners of mutation carriers reporting the most difficulties.